Literature DB >> 79920

Renal prostaglandins in systemic lupus erythematosus.

R P Kimberly.   

Abstract

Inhibition of prostaglandin synthesis at the prostaglandin synthetase and phospholipase steps could account for acute changes in renal function which are sometimes induced in patients with systemic lupus erythematosus (S.L.E.) by nonsteroidal anti-inflammatory drugs and high-dose corticosteriids, respectively. Renal function in S.L.E. patients seems to be more susceptible to inhibition of prostaglandin synthesis than in normal subjects. This susceptibility, in conjunction with increased urinary excretion of prostaglandin compounds, indicates that renal function in S.L.E. patients may depend on enhanced renal prostaglandin production for the maintenance of renal haemodynamics.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 79920     DOI: 10.1016/s0140-6736(78)92886-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Lupus nephritis. Middlesex, October 20, 1988. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

Review 2.  The third Lilly Prize Lecture. University of London, January, 1979. The nephrotoxicity and hepatotoxicity of antipyretic analgesics.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

Review 3.  Systemic lupus erythematosus: treatment and prognosis.

Authors:  G R Hughes
Journal:  Br Med J       Date:  1979-10-27

Review 4.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

5.  The role of renal prostaglandin E as a possible modulator of cyclic AMP production in nephrotic syndrome.

Authors:  S Túri; Z Havass; T Bodrogi
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.